Conference Coverage

Cognitive impairment signals subclinical vascular disease

Publish date: June 12, 2015

 

AT THE EUROPEAN STROKE CONFERENCE

References

The original trial was supported by an investigator-initiated grant from Bristol-Myers Squibb, USA. Ms. Rostamian had no conflicts.

Pages

Recommended Reading

AF patients receive unnecessary oral anticoagulants
MDedge Neurology
Aspirin for AF fading away
MDedge Neurology
Novel oral anticoagulants best warfarin for AF in heart failure
MDedge Neurology
Fondaparinux safe for VTE prophylaxis in ischemic stroke
MDedge Neurology
Androgen deprivation linked to cognitive impairment
MDedge Neurology
Carotid artery stenosis guidelines need modernizing
MDedge Neurology
Traditional diagnostic criteria miss OSA in coronary artery disease patients
MDedge Neurology
IHC: IV dihydroergotamine linked to increased thrombosis risk
MDedge Neurology
‘Modest’ uptake of novel anticoagulants in real-world practice
MDedge Neurology
Handheld ECG helps spot atrial fibrillation after stroke
MDedge Neurology